Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241713550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rosaria Tinnirello und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Via E. Tricomi 5, 90127 Palermo, Ita…. Hauptthemen laut MEDLINE: Glioblastoma, Zika Virus, Zika Virus Infection. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health, Ricerca Corrente.
Abstract (Originalsprache)
Neural stem cells (NSCs) were described for the first time more than two decades ago for their ability to differentiate into all neural cell lineages. The isolation of NSCs from adults and embryos was carried out by various laboratories and in different species, from mice to humans. Similarly, no more than two decades ago, cancer stem cells were described. Cancer stem cells, previously identified in hematological malignancies, have now been isolated from several solid tumors (breast, brain, and gastrointestinal compartment). Though the origin of these cells is still unknown, there is a wide consensus about their role in tumor onset, propagation and, in particular, resistance to treatments. Normal and neoplastic neural stem cells share common characteristics, and can thus be considered as two sides of the same coin. This is particularly true in the case of the Zika virus (ZIKV), which has been described as an inhibitor of neural development by specifically targeting NSCs. This understanding prompted us and other groups to evaluate ZIKV action in glioblastoma stem cells (GSCs). The results indicate an oncolytic activity of this virus vs. GSCs, opening potentially new possibilities in glioblastoma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research, IRCCS ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Via E. Tricomi 5, 90127 Palermo, Italy.
- Regenerative Medicine and Immunotherapy Area, Fondazione Ri.MED c/o IRCCS ISMETT, 90127 Palermo, Italy.
ORCID-Profile: Cinzia Maria Chinnici, Vitale Miceli, Matteo Bulati, Alessia Gallo, Giovanni Zito, Pier Giulio Conaldi, Gioacchin Iannolo
Förderung
- Ministero della Salute
- Italian Ministry of Health, Ricerca Corrente
Zitieren
APA
Tinnirello, R., Chinnici, C. M., Miceli, V., Busà, R., Bulati, M., Gallo, A., Zito, G., Conaldi, P. G., & Iannolo, G. (2023). Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713550
Vancouver
Tinnirello R, Chinnici CM, Miceli V, Busà R, Bulati M, Gallo A, et al. Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713550
BibTeX
@article{Tinnirello2023,
author = {Tinnirello, Rosaria and Chinnici, Cinzia Maria and Miceli, Vitale and Busà, Rosalia and Bulati, Matteo and Gallo, Alessia and Zito, Giovanni and Conaldi, Pier Giulio and Iannolo, Gioacchin},
title = {Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713550}
}
EUVIMED